Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome

被引:0
|
作者
Kyeong Ho Yun
Myung Ho Jeong
Seok Kyu Oh
Sang Jae Rhee
Eun Mi Park
Eun Mi Lee
Nam Jin Yoo
Nam-Ho Kim
Young Keun Ahn
Jin-Won Jeong
机构
[1] Wonkwang University Hospital,Department of Cardiovascular Medicine
[2] Chonnam National University Hospital,Department of Cardiovascular Medicine
来源
Heart and Vessels | 2009年 / 24卷
关键词
Percutaneous coronary angioplasty; Stent; C-reactive protein; Inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
Percutaneous coronary intervention (PCI) provokes an inflammatory reaction, as shown by increased concentrations of plasma C-reactive protein (CRP) after PCI. However, the changes of CRP levels after PCI in patients with acute coronary syndrome (ACS) have not been well evaluated. We evaluated the characteristics of the patients with elevated CRP response after PCI and whether an increase in CRP after PCI predicts long-term prognosis in patients with ACS. We studied consecutive 360 patients with ACS who underwent elective coronary stenting. Inflammatory response to PCI was calculated as the difference between the peak postprocedural hsCRP level and the preprocedural hsCRP level (ΔCRP). Twelve months follow-up data were obtained and clinical outcomes were compared with ΔCRP. In receiver operating characteristics analyses, the cutoff point of ΔCRP for major adverse cardiac events (MACE) was 3.0 mg/l, which yielded sensitivity of 61.7% and specificity of 69.7%. The patients with ΔCRP > 3 mg/l revealed higher incidence of myocardial infarction (37.7 vs 14.6%, P < 0.001), and ACC/AHA type B2/C lesion (81.5 vs 68.7%, P = 0.006) than in patients with low ΔCRP. White blood cell count, low-density lipoprotein cholesterol, peak creatinine kinase-MB, and peak troponin T were significantly elevated in patients with ΔCRP > 3 mg/l than in those with ≤3 mg/l. There was significant correlation between ΔCRP and the changes in troponin T after PCI (r = 0.210, P < 0.001). An increase in hsCRP > 3 mg/l after PCI had a higher predictive value for the occurrence of MACE than low hsCRP elevation (hazard ratio 2.1, P = 0.005). In multivariate analysis, ΔCRP and peak troponin T were independent predictors of MACE (P < 0.001 and P = 0.013, respectively). In conclusion, postprocedural hsCRP elevation >3 mg/l was associated with higher incidence of MACE in patients with ACS. ΔCRP determinations may be of value for risk stratification after PCI.
引用
收藏
页码:175 / 180
页数:5
相关论文
共 50 条
  • [1] Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome
    Yun, Kyeong Ho
    Jeong, Myung Ho
    Oh, Seok Kyu
    Rhee, Sang Jae
    Park, Eun Mi
    Lee, Eun Mi
    Yoo, Nam Jin
    Kim, Nam-Ho
    Ahn, Young Keun
    Jeong, Jin-Won
    HEART AND VESSELS, 2009, 24 (03) : 175 - 180
  • [2] Prognostic values of high-sensitivity C-reactive protein for patients receiving percutaneous coronary intervention.
    Tan, Zheng
    Li, Li
    Ma, Yi
    Geng, Xuebin
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (04): : 1906 - 1910
  • [3] Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention
    Yuan, Deshan
    Wang, Peizhi
    Jia, Sida
    Zhang, Ce
    Zhu, Pei
    Jiang, Lin
    Liu, Ru
    Xu, Jingjing
    Tang, Xiaofang
    Song, Ying
    Yao, Yi
    Xu, Na
    Zhang, Yin
    Zhao, Xueyan
    Yang, Yuejin
    Xu, Bo
    Gao, Lijian
    Gao, Zhan
    Gao, Runlin
    Yuan, Jinqing
    ATHEROSCLEROSIS, 2022, 363 : 109 - 116
  • [4] Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention
    Liu, Yue
    Jia, Si-da
    Yao, Yi
    Tang, Xiao-fang
    Xu, Na
    Jiang, Lin
    Gao, Zhan
    Chen, Jue
    Yang, Yue-jin
    Gao, Run-lin
    Xu, Bo
    Yuan, Jin-qing
    JOURNAL OF CARDIOLOGY, 2020, 75 (01) : 60 - 65
  • [5] Prognostic Impact of High-Sensitivity C-Reactive Protein in Patients Undergoing Percutaneous Coronary Intervention According to BMI
    Beyhoff, Niklas
    Cao, Davide
    Mehran, Roxana
    Dangas, George
    Baber, Usman
    Sartori, Samantha
    Blum, Moritz
    Roumeliotis, Anastasios
    Chandiramani, Rishi
    Goel, Ridhima
    Zhang, Zhongjie
    Kovacic, Jason
    Krishnan, Prakash
    Barman, Nitin
    Kapur, Vishal
    Sweeny, Joseph
    Sharma, Samin K.
    Kini, Annapoorna
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (24) : 2882 - 2892
  • [6] Prognostic efficacy of high-sensitivity C-reactive protein to albumin ratio in patients with acute coronary syndrome
    Wang, Wei
    Ren, Dong
    Wang, Chun-Song
    Li, Tai
    Yao, Heng-Chen
    Ma, Sheng-Jun
    BIOMARKERS IN MEDICINE, 2019, 13 (10) : 811 - 820
  • [7] TO EXPLORE THE RELATIONSHIP BETWEEN HIGH-SENSITIVITY C-REACTIVE PROTEIN AND THE PROGNOSIS OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AFTER PERCUTANEOUS CORONARY INTERVENTION
    Sun Xiao-dan
    Zhang Yue-lan
    HEART, 2010, 96 : A154 - A154
  • [8] PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REACTIVE PROTEIN AND LIPOPROTEIN (a) IN ACUTE MYOCARDIAL INFARCTION PATIENTS RECEIVING EMERGENCY PERCUTANEOUS CORONARY INTERVENTION
    Ding, Shifang
    Peng, Yi
    Chen, Zhinan
    Jiang, Juquan
    Gong, Zhigang
    Li, Zhigang
    Lu, Qing
    Wang, Renxue
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2012, 31 (02) : 131 - 134
  • [9] Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome
    Otake, Hiromasa
    Shite, Junya
    Shinke, Toshiro
    Watanabe, Satoshi
    Tanino, Yusuke
    Ogasawara, Daisuke
    Sawada, Takahiro
    Hirata, Ken-ichi
    Yokoyama, Mitsuhiro
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (01): : 1 - 7
  • [10] Clinical Significance of High-Sensitivity C-Reactive Protein in Patients with Preserved Renal Function Following Percutaneous Coronary Intervention
    Shimizu, Takashi
    Suwa, Satoru
    Dohi, Tomotaka
    Wada, Hideki
    Miyauchi, Katsumi
    Shitara, Jun
    Endo, Hirohisa
    Doi, Shinichiro
    Ogita, Manabu
    Kasai, Takatoshi
    Okazaki, Shinya
    Isoda, Kikuo
    Daida, Hiroyuki
    INTERNATIONAL HEART JOURNAL, 2019, 60 (05) : 1037 - 1042